These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20032217)

  • 1. Immunologic indicators of clinical progression during canine Leishmania infantum infection.
    Boggiatto PM; Ramer-Tait AE; Metz K; Kramer EE; Gibson-Corley K; Mullin K; Hostetter JM; Gallup JM; Jones DE; Petersen CA
    Clin Vaccine Immunol; 2010 Feb; 17(2):267-73. PubMed ID: 20032217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania infantum-specific production of IFN-γ and IL-10 in stimulated blood from dogs with clinical leishmaniosis.
    Solano-Gallego L; Montserrrat-Sangrà S; Ordeix L; Martínez-Orellana P
    Parasit Vectors; 2016 Jun; 9(1):317. PubMed ID: 27260142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
    Schaut RG; Grinnage-Pulley TL; Esch KJ; Toepp AJ; Duthie MS; Howard RF; Reed SG; Petersen CA
    Vaccine; 2016 Oct; 34(44):5225-5234. PubMed ID: 27665354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum.
    Santos-Gomes GM; Rosa R; Leandro C; Cortes S; Romão P; Silveira H
    Vet Immunol Immunopathol; 2002 Sep; 88(1-2):21-30. PubMed ID: 12088641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
    Daneshvar H; Molaei MM; Kamiabi H; Burchmore R; Hagan P; Stephen Phillips R
    Parasite Immunol; 2010; 32(11-12):722-30. PubMed ID: 21039612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine visceral leishmaniasis: a comparative study of real-time PCR, conventional PCR, and direct agglutination on sera for the detection of Leishmania infantum infection.
    Mohammadiha A; Haghighi A; Mohebali M; Mahdian R; Abadi AR; Zarei Z; Yeganeh F; Kazemi B; Taghipour N; Akhoundi B; Barati M; Mahmoudi MR
    Vet Parasitol; 2013 Feb; 192(1-3):83-90. PubMed ID: 23153824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total serum IgD from healthy and sick dogs with leishmaniosis.
    Martínez-Orellana P; Maristany C; Baxarias M; Álvarez-Fernández A; Baldassarre A; Ordeix L; Solano-Gallego L
    Parasit Vectors; 2019 Mar; 12(1):119. PubMed ID: 30909975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 receptor blockade controls the in vitro infectivity of Leishmania infantum and promotes a Th1 activation in PBMC of dogs with visceral leishmaniasis.
    de Oliveira Cardoso JM; de Brito RCF; Costa AFP; Siqueira Mathias FA; Soares Reis LE; Vieira JFP; de Oliveira Aguiar Soares RD; Reis AB; Roatt BM
    Mol Immunol; 2021 Sep; 137():20-27. PubMed ID: 34182228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania infantum-specific IFN-γ production in stimulated blood from cats living in areas where canine leishmaniosis is endemic.
    Priolo V; Martínez-Orellana P; Pennisi MG; Masucci M; Prandi D; Ippolito D; Bruno F; Castelli G; Solano-Gallego L
    Parasit Vectors; 2019 Mar; 12(1):133. PubMed ID: 30909952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long term experimental study of canine visceral leishmaniasis.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Int J Parasitol; 2007 May; 37(6):683-93. PubMed ID: 17239885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
    Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an Interferon Gamma Release Assay (IGRA) to test T-cell responsiveness to soluble Leishmania infantum antigen in whole blood of dogs from endemic areas.
    Zribi L; El-Goulli AF; Ben-Abid M; Gharbi M; Ben-Sghaier I; Boufaden I; Aoun K; Bouratbine A
    Vet Parasitol; 2017 Nov; 246():88-92. PubMed ID: 28969786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An experimental protocol for the establishment of dogs with long-term cellular immune reactions to Leishmania antigens.
    Teixeira MC; Oliveira GG; Santos PO; Bahiense TC; da Silva VM; Rodrigues MS; Larangeira DF; Dos-Santos WL; Pontes-de-Carvalho LC
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):182-9. PubMed ID: 21537678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic immune responses during canine visceral leishmaniasis.
    Strauss-Ayali D; Baneth G; Jaffe CL
    Vet Res; 2007; 38(4):547-64. PubMed ID: 17540157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis.
    Nieto CG; García-Alonso M; Requena JM; Mirón C; Soto M; Alonso C; Navarrete I
    Vet Immunol Immunopathol; 1999 Feb; 67(2):117-30. PubMed ID: 10077418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological profile of resistance and susceptibility in naturally infected dogs by Leishmania infantum.
    de Almeida Leal GG; Roatt BM; de Oliveira Aguiar-Soares RD; Carneiro CM; Giunchetti RC; Teixeira-Carvalho A; Martins-Filho OA; Francisco AF; Cardoso JM; Mathias FA; Correa-Oliveira R; Carneiro M; Coura-Vital W; Reis AB
    Vet Parasitol; 2014 Oct; 205(3-4):472-82. PubMed ID: 25234767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex-vivo whole blood from sick and resistant dogs.
    Martínez-Orellana P; Quirola-Amores P; Montserrat-Sangrà S; Ordeix L; Llull J; Álvarez-Fernández A; Solano-Gallego L
    Parasit Vectors; 2017 Mar; 10(1):123. PubMed ID: 28288677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.